
STAT NEWS · 2026-11-04 12:30 UTC
Former Madrigal Pharmaceuticals executive alleges coverup of safety issues of its drug
Michael Charlton, former senior VP of clinical development at Madrigal Pharmaceuticals, filed a federal lawsuit alleging he was forced to resign after raising safety concerns about the company's MASH drug. Charlton's lawsuit, filed Oct. 9 in Northern District of Illinois, accuses Madrigal of retaliation under federal whistleblower-protection statutes and seeks reinstatement or damages. Charlton served in the role from October 2024 to January 2026 and was tasked with safeguarding safety and scientific integrity of clinical trials.
Loading the story on Tree News…